| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;115:450-458.)
© 2007 American Heart Association, Inc.
Epidemiology |
From the Department of Public Health and Primary Care, University of Cambridge (N.S., J.D., K.-T.K.), MRC Epidemiology Unit (N.W.), MRC Dunn Nutrition Unit, and MRC Centre for Nutrition and Cancer Prevention and Survival (S.B.), Cambridge, England; Icelandic Heart Association, Kopavogur, Iceland (G.E., G.S., V.G.); and Academic Medical Center, Amsterdam, the Netherlands (S.M.B.).
Correspondence to Professor John Danesh, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, CB1 8RN, UK. E-mail john.danesh{at}phpc.cam.ac.uk
Received May 2, 2006; revision received September 13, 2006; accepted September 29, 2006.
Background— Many epidemiological studies have reported on associations between serum triglyceride concentrations and the risk of coronary heart disease, but this association has not been reliably quantified. In the present study, we report 2 separate nested case-control comparisons in 2 different prospective, population-based cohorts, plus an updated meta-analysis of 27 additional prospective studies in general Western populations.
Methods and Results— Measurements were made in a total of 3582 incident cases of fatal and nonfatal coronary heart disease and 6175 controls selected from among the 44 237 men and women screened in the Reykjavik and the European Prospective Investigation of Cancer (EPIC)-Norfolk studies. Repeat measurements were obtained an average of 4 years apart in 1933 participants in the EPIC-Norfolk Study and an average of 12 years apart in 379 participants in the Reykjavik study. The long-term stability of log-triglyceride values (within-person correlation coefficients of 0.64 [95% CI, 0.60 to 0.68] over 4 years and 0.63 [95% CI, 0.57 to 0.70] over 12 years) was similar to those of blood pressure and total serum cholesterol. After adjustment for baseline values of several established risk factors, the strength of the association was substantially attenuated, and the adjusted odds ratio for coronary heart disease was 1.76 (95% CI, 1.39 to 2.21) in the Reykjavik study and 1.57 (95% CI, 1.10 to 2.24) in the EPIC-Norfolk study in a comparison of individuals in the top third with those in the bottom third of usual log-triglyceride values. Similar overall findings (adjusted odds ratio, 1.72; 95% CI, 1.56 to 1.90) were observed in an updated meta-analysis involving a total of 10 158 incident coronary heart disease cases from 262 525 participants in 29 studies.
Conclusions— Available prospective studies in Western populations consistently indicate moderate and highly significant associations between triglyceride values and coronary heart disease risk. Because these associations depend considerably on levels of established risk factors, however, further studies are needed to help assess the nature of any independent associations.
Related Article:
This article has been cited by other articles:
![]() |
S. Bingham, R. Luben, A. Welch, Y. L. Low, K. T. Khaw, N. Wareham, and N. Day Associations between dietary methods and biomarkers, and between fruits and vegetables and risk of ischaemic heart disease, in the EPIC Norfolk Cohort Study Int. J. Epidemiol., June 25, 2008; (2008) dyn111v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D Furtado, H. Campos, L. J Appel, E. R Miller, N. Laranjo, V. J Carey, and F. M Sacks Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1623 - 1630. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Frempong, M. Ricks, S. Sen, and A. E. Sumner Effect of Low-Dose Oral Contraceptives on Metabolic Risk Factors in African-American Women J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2097 - 2103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Svensson, E. B. Schmidt, K. A. Jorgensen, and J. H. Christensen The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study Nephrol. Dial. Transplant., April 24, 2008; (2008) gfn180v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Brunzell, M. Davidson, C. D. Furberg, R. B. Goldberg, B. V. Howard, J. H. Stein, and J. L. Witztum Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus Conference Report From the American Diabetes Association and the American College of Cardiology Foundation J. Am. Coll. Cardiol., April 15, 2008; 51(15): 1512 - 1524. [Full Text] [PDF] |
||||
![]() |
J. D. Brunzell, M. Davidson, C. D. Furberg, R. B. Goldberg, B. V. Howard, J. H. Stein, and J. L. Witztum Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation Diabetes Care, April 1, 2008; 31(4): 811 - 822. [Full Text] [PDF] |
||||
![]() |
A. Bennet, E. Di Angelantonio, S. Erqou, G. Eiriksdottir, G. Sigurdsson, M. Woodward, A. Rumley, G. D. O. Lowe, J. Danesh, and V. Gudnason Lipoprotein(a) Levels and Risk of Future Coronary Heart Disease: Large-Scale Prospective Data Arch Intern Med, March 24, 2008; 168(6): 598 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Broadbent, J. F. Peden, S. Lorkowski, A. Goel, H. Ongen, F. Green, R. Clarke, R. Collins, M. G. Franzosi, G. Tognoni, et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p Hum. Mol. Genet., March 15, 2008; 17(6): 806 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miller, C. P. Cannon, S. A. Murphy, J. Qin, K. K. Ray, E. Braunwald, and for the PROVE IT-TIMI 22 Investigators Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial. J. Am. Coll. Cardiol., February 19, 2008; 51(7): 724 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, R. Qi, X. Xian, F. Yang, M. Blackstein, X. Deng, J. Fan, C. Ross, J. Karasinska, M. R. Hayden, et al. Spontaneous Atherosclerosis in Aged Lipoprotein Lipase-Deficient Mice With Severe Hypertriglyceridemia on a Normal Chow Diet Circ. Res., February 1, 2008; 102(2): 250 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M Ridker Fasting versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test? Clin. Chem., January 1, 2008; 54(1): 11 - 13. [Full Text] [PDF] |
||||
![]() |
J. Wang, H. Cao, M. R. Ban, B. A. Kennedy, S. Zhu, S. Anand, S. Yusuf, R. L. Pollex, and R. A. Hegele Resequencing Genomic DNA of Patients With Severe Hypertriglyceridemia (MIM 144650) Arterioscler. Thromb. Vasc. Biol., November 1, 2007; 27(11): 2450 - 2455. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tirosh, A. Rudich, T. Shochat, D. Tekes-Manova, E. Israeli, Y. Henkin, I. Kochba, and I. Shai Changes in Triglyceride Levels and Risk for Coronary Heart Disease in Young Men Ann Intern Med, September 18, 2007; 147(6): 377 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Criqui Triglycerides and Coronary Heart Disease Revisited (Again) Ann Intern Med, September 18, 2007; 147(6): 425 - 427. [Full Text] [PDF] |
||||
![]() |
B. G. Nordestgaard, M. Benn, P. Schnohr, and A. Tybjaerg-Hansen Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women JAMA, July 18, 2007; 298(3): 299 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bansal, J. E. Buring, N. Rifai, S. Mora, F. M. Sacks, and P. M Ridker Fasting Compared With Nonfasting Triglycerides and Risk of Cardiovascular Events in Women JAMA, July 18, 2007; 298(3): 309 - 316. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |